Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples